ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.72
      0.00%
      Bitcoin
      98,133.75
      0.38%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Inhibrx Biosciences Inc (INBX) Quote

      Inhibrx Biosciences Inc

      Inhibrx Biosciences Inc (INBX)

      NASDAQ
      14.60
      0.72
      (5.19%)
      Closed December 21 4:00PM
      Delayed by 15 minutes
      14.60
      0.03
      (0.21%)
      After Hours: 6:55PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      14.60
      Bid
      13.00
      Ask
      14.60
      Volume
      270,828
      13.51 Day's Range 14.72
      10.80 52 Week Range 39.79
      Market Cap
      211.348M
      Previous Close
      13.88
      Open
      13.70
      Last Trade
      189
      @
      14.6
      (priorref)
      Last Trade Time
      Financial Volume
      $ 3,753,767
      VWAP
      13.8603
      Average Volume (3m)
      72,412
      Shares Outstanding
      14,475,904
      Dividend Yield
      -
      PE Ratio
      -1.48
      Earnings Per Share (EPS)
      -10.71
      Revenue
      1.63M
      Net Profit
      -154.96M

      About Inhibrx Biosciences Inc

      We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.inhibrx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INBX. The last closing price for Inhibrx Biosciences was $13.88. Over the last year, Inhibrx Biosciences shares have traded in a share price range of $ 10.80 to $ 39.79.

      Inhibrx Biosciences currently has 14,475,904 shares outstanding. The market capitalization of Inhibrx Biosciences is $200.93 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.48.

      Ask ADVFN Intelligence (AI)

      INBX Latest News

      More News

      FeaturedHertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing

      21 hours ago

      Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

      Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx...

      November 14 2024
      PR Newswire (US)

      Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

      Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc...

      November 04 2024
      PR Newswire (US)

      Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

      Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...

      August 13 2024
      PR Newswire (US)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 31 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 30 2024
      Edgar (US Regulatory)

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      May 30 2024
      Edgar (US Regulatory)

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      May 30 2024
      Edgar (US Regulatory)

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      May 30 2024
      Edgar (US Regulatory)

      Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

      May 30 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.29-1.9476158495614.8915.2413.586904614.26523997CS
      40.60794.3445944497313.992116.213.587009514.84531621CS
      12-0.73-4.761904761915.3317.4112.257241215.20271046CS
      260.140.96818810511814.4617.7910.810845914.57257574CS
      52-15.17-50.957339603629.7739.7910.839000931.78197035CS
      156-28.58-66.188050023243.1845.9897.6742587725.16753556CS
      260-5.1-25.888324873119.750.977.6734291925.87712206CS

      INBX - Frequently Asked Questions (FAQ)

      What is the current Inhibrx Biosciences share price?
      The current share price of Inhibrx Biosciences is $ 14.60
      How many Inhibrx Biosciences shares are in issue?
      Inhibrx Biosciences has 14,475,904 shares in issue
      What is the market cap of Inhibrx Biosciences?
      The market capitalisation of Inhibrx Biosciences is USD 200.93M
      What is the 1 year trading range for Inhibrx Biosciences share price?
      Inhibrx Biosciences has traded in the range of $ 10.80 to $ 39.79 during the past year
      What is the PE ratio of Inhibrx Biosciences?
      The price to earnings ratio of Inhibrx Biosciences is -1.48
      What is the cash to sales ratio of Inhibrx Biosciences?
      The cash to sales ratio of Inhibrx Biosciences is 140.48
      What is the reporting currency for Inhibrx Biosciences?
      Inhibrx Biosciences reports financial results in USD
      What is the latest annual turnover for Inhibrx Biosciences?
      The latest annual turnover of Inhibrx Biosciences is USD 1.63M
      What is the latest annual profit for Inhibrx Biosciences?
      The latest annual profit of Inhibrx Biosciences is USD -154.96M
      What is the registered address of Inhibrx Biosciences?
      The registered address for Inhibrx Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Inhibrx Biosciences website address?
      The website address for Inhibrx Biosciences is www.inhibrx.com
      Which industry sector does Inhibrx Biosciences operate in?
      Inhibrx Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MYSZMy Size Inc
      $ 4.2001
      (211.12%)
      		120.01M
      NVNINVNI Group Ltd
      $ 8.26
      (209.36%)
      		76.64M
      TPICTPI Composites Inc
      $ 2.45
      (100.82%)
      		33.95M
      ICGIntchains Group Ltd
      $ 8.77
      (88.60%)
      		527.61k
      HSDTHelius Medical Technologies Inc
      $ 0.884851
      (84.34%)
      		120.4M
      CYNCYNGN Inc
      $ 0.4603
      (-71.41%)
      		27.91M
      MTEMMolecular Templates Inc
      $ 0.1502
      (-57.09%)
      		8.75M
      PRFXPainReform Ltd
      $ 5.15
      (-53.85%)
      		2.94M
      GALTGalectin Therapeutics Inc
      $ 1.03
      (-48.50%)
      		9.27M
      BCABBioAtla Inc
      $ 0.6923
      (-41.82%)
      		6.25M
      EDBLEdible Garden AG Inc
      $ 0.24
      (65.06%)
      		354.33M
      NVDANVIDIA Corporation
      $ 134.70
      (3.08%)
      		310.19M
      APTOAptose Biosciences Inc
      $ 0.28
      (64.51%)
      		306.25M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.606999
      (6.49%)
      		293.22M
      PLTRPalantir Technologies Inc
      $ 80.55
      (8.54%)
      		281.23M

      INBX Discussion

      View Posts
      Monksdream Monksdream 2 months ago
      INBX under $20
      👍️0
      Monksdream Monksdream 3 months ago
      INBX under $20
      👍️0
      Monksdream Monksdream 3 months ago
      INBX under $15
      👍️0
      Monksdream Monksdream 8 months ago
      INBX over $30
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      heres the dolla...boom!!
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      INBX DOLLA RUMMER IN PROCESS
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      INBX...PRE MARKET VOL
      👍️0
      Jaydixson1 Jaydixson1 2 years ago
      Seems to be dropping
      👍️0
      make it happen make it happen 2 years ago
      Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

      Profitability
      Profit Margin 0.00%
      Operating Margin -1,448.76%

      Management Effectiveness
      Return on Assets -37.98%
      Return on Equity -562.25%

      Income Statement
      Revenue 7.03M
      Revenue Per Share 0.18
      Quarterly Revenue Growth (yoy) -25.50%
      Gross Profit -64.21M
      EBITDA -100.6M
      Net Income Avi to Common -110.75M
      Diluted EPS -2.44

      Balance Sheet
      Total Debt 175.7M
      Book Value Per Share -0.13

      Cash Flow Statement
      Operating Cash Flow -90.16M
      Levered Free Cash Flow -46.31M
      👍️0

      Your Recent History

      NASDAQ
      INBX
      Inhibrx Biosciences
      BIT
      NSCITCB02221
      International Bank for R...
      LSE
      47TP
      Res Mtg 13 Nt36
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads